# Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen Alone in Subjects With Advanced Digestive System Neoplasms

> **NCT06019702** · PHASE1 · RECRUITING · sponsor: **Sir Run Run Shaw Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Digestive System Neoplasms

## Interventions

- **BIOLOGICAL:** iNeo-Vac-R01

## Key facts

- **NCT ID:** NCT06019702
- **Lead sponsor:** Sir Run Run Shaw Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-08
- **Primary completion:** 2027-08-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2023-09-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06019702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06019702, "Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen Alone in Subjects With Advanced Digestive System Neoplasms". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06019702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*